Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal Transplant or Cataract Surgery

NCT04975971 is registered in ClinicalTrials.gov with Nicole Fram M.D. as lead sponsor.

NCT NCT04975971
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04975971 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal Transplant or Cataract Surgery
Lead sponsor
Nicole Fram M.D.
Phase
Observational
Overall status
Completed
Start date
March 9, 2021
Completion date
May 19, 2021
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anterior chamber inflammation, cataract senile, corneal defect, corneal edema, cortical cataract, nuclear cataract, ocular pain, penetrating keratoplasty